+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Shigellosis Drug"

Shigellosis - Pipeline Insight, 2024 - Product Thumbnail Image

Shigellosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
From
From
Bacillary Dysentery - Pipeline Review, H2 2019 - Product Thumbnail Image

Bacillary Dysentery - Pipeline Review, H2 2019

  • Drug Pipelines
  • November 2019
  • 55 Pages
  • Global
From
  • 5 Results (Page 1 of 1)
Loading Indicator

Shigellosis is an infectious disease caused by a group of bacteria known as Shigella. Treatment of shigellosis typically involves antibiotics, such as ciprofloxacin, ceftriaxone, and azithromycin. The Shigellosis Drug market is a subset of the larger Infectious Diseases Drugs market, which includes drugs used to treat a variety of bacterial, viral, and fungal infections. The Shigellosis Drug market is composed of a variety of pharmaceutical companies that develop and manufacture drugs to treat shigellosis. These companies are typically involved in the research and development of new drugs, as well as the production and distribution of existing drugs. Companies in the Shigellosis Drug market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Novartis. Show Less Read more